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A prevalence study of epilepsy in patients with Down syndrome (n = 85) in three age-groups (14-16 years, 23-29 
years, 50-60 years) was conducted in the county of Aarhus, Denmark. Seventy-two patients (85%) participated. 
An interview and a neurological examination were performed. An EEG was recorded in 50 patients. Twelve 
patients (17%) had epilepsy. ILAE-1981-classification: two with partial seizures, seven with primary generalized 
and three with unclassifiable g neralized seizures. Two patients with epilepsy had a normal EEG and 13 patients 
without epilepsy had an abnormal EEG. 
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INTRODUCTION 
Down syndrome (trisomy (21) is the most 
frequent chromosomal disorder causing mental 
retardation 1"2. Patients with Down syndrome 
have an increased prevalence of complicating 
diseases including epilepsy, cardiac disease, hear- 
ing and vision disorders and gastrointestinal 
disorders 3. Epilepsy is seen in 20-40% of persons 
with mental retardation 4"5with increased pre- 
valence the more disabled the patient is. Preval- 
ence studies on epilepsy in Down syndrome have 
shown conflicting results ranging from zero 6 to 
15.9% 7 . An overview of the literature until 1991 
concerning the prevalence of epilepsy in Down 
syndrome has been made by Stafstrom 8. Since 
then Collacott in 19939 and Prasher in 19957 in 
population studies have described that the pre- 
valence of epilepsy in Down syndrome increases 
with age. These studies are to our knowledge the 
only population based studies of the prevalence 
of epilepsy in Down syndrome, where the study 
of Collacott 9 includes a total population and the 
population in the study of Prasher is considered 
to be relatively representative. 
§ Presented in part at the 3rd International Symposium on 
Brain Dysfunction. Troina, Italy. September 30, 1994. 
In 1974 Veall I° described a biphasic prevalence 
of epilepsy in Down syndrome with a maximum 
between 30 and 34 years of age and over 55 years 
of age. In 1991 Pueschel ~ described a biphasic 
incidence of epilepsy in Down syndrome with a 
peak incidence under the age of one year and 
between 20 and 30 years. Pueschel suggested that 
a comination of these data could suggest a 
triphasic distribution of epilepsy in Down 
syndrome 1 i, i.e. infancy epilepsy, early adulthood 
epilepsy, and a special epilepsy in patients over 
50-55 years. 
The type of epilepsy in Down syndrome has 
been described in several papers ~2-~5. All these 
studies are based on selected populations of 
mainly children institutionalized or living at 
home. Some of the studies have focused on 
specific seizure types or syndromes uch as 
reflex-seizures, Lennox-Gastaut and West syn- 
drome, while other studies have focused on 
dementia in Down syndrome m6'~7. To our know- 
ledge only the most recent study of Prasher 7 has 
addressed the question of seizure type in a 
population study of Down syndrome. 
The aim of the present study was to assess the 
prevalence and type of epilepsy and epileptic 
seizures in an epidemiologically well described 
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population of patients with Down syndrome in 
selected age groups. 
METHOD 
The study comprised all members of three age 
groups of patients with Down syndrome born 
1934-43, 1965-70, and 1977-80, who lived in the 
County of Aarhus, Denmark, in 1984. All 
patients participated in a survey study of health 
care services and social conditions in 1984-85. 
The search for patients through the Danish 
Register of Persons with Mental Retardation and 
through inquiries to the city councils are de- 
scribed in detail elsewhere 18-2°. These three age 
groups were selected for study because they are 
considered to include all patients with Down 
syndrome in the county of Aarhus in 1984 and 
because of the extensive pidemiological data on 
the patients that have been reported previously 21. 
The population of the county of Aarhus (approx. 
614000 inhabitants) is considered emographi- 
cally representative for the total population of 
Denmark. The patients (parents/carers) were 
contacted by letter. A response was eventually 
obtained from all patients in the selected 
population. 
In 1994, the total study group consisted of 85 
persons with Down syndrome. Seventy-two 
(85%) agreed to participate. Age, sex, and 
number of participants and those who refused to 
participate are shown in Table 1. There are no 
differences in age, gender or residence between 
those participating and those who did not. All but 
one have been diagnosed cytogenetically. Of the 
71 patients with a cytogenetic diagnosis five 
patients were mosaics, while the rest were 
trisomies. The patient who was not diagnosed 
cytogenetically (severely mentally retarded, male, 
55 years) was diagnosed clinically by experienced 
clinicians as having Down syndrome. 
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The study was carried out between 1 March, 
1994 and 1 September, 1994. Parents and/or 
carers (and patients) were interviewed semistruc- 
tured (performed by P.J.) either at home or at the 
outpatient clinic at the Department of Neurology, 
Aarhus University Hospital. The interview ex- 
plored previous medical history including birth 
problems, present medical condition, medication, 
activities of daily living and workshop perfor- 
mance. Information concerning fits or seizures 
was extensively explored. Any changes in capabi- 
lities were registered. A neurological and general 
physical examination was performed as far as the 
patient could cooperate. The definition and 
classification of epilepsy were based on the 
clinical description and EEG according to the 
'1981-Classification' of ILAE 22. 
All the 72 patients that were examined were 
asked to have an EEG. A conventional EEG 
recording with either standard 8 or 16 leads using 
surface electrodes was performed in 50 patients. 
In 22 cases the carers refused to let the patient 
have an EEG performed because they found the 
EEG-recording too time consuming or too 
unpleasant for the patient who would not benefit 
from it him/herself. The EEG was described 
independently by both an EEG-technician and a 
neurophysiologist (J.E.J.C.). They only knew the 
diagnosis of Down syndrome and the age of the 
patient. The EEG abnormalities were classified in 
four different groups: (1) epileptic activity (par- 
oxysmal activity and/or spikes/sharp-waves), (2) 
reduced frequency of the dominant background 
activity (i.e. <8 Hz), (3) abnormal low frequency 
(=<4Hz) with a non-focal distribution with or 
without preponderance or (4) abnormal low- 
frequency with a focal distribution. More than 
one abnormality could be present in the same 
EEG. 
The study was in accordance with the Helsinki 
II declaration and was approved by the ethical 
committee for the County of Aarhus. Informed 
Table 1: Total population and number, age, and sex of participating and 
non-participating patients 
Group 1 2 3 Total 
Total population (n) 15 41 29 85 
Participating (n) 13 34 25 72 
Mean age (yr) 14.8 25.9 54.3 
(range) (14-16) (23-29) (50-60) 
Sex (M/F) 6/7 24/10 15/10 45/27 
Non-participating (n) 2 7 4 13 
Mean age (yr) 16.0 27.1 54.3 
(range) (16) (24-29) (49-59) 
Sex (M/F) 1/1 4/3 3/I 8/5 
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consent was obtained from the patients including 
a written informed consent from parents or 
carers. 
RESULTS 
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In two patients with generalized tonic-clonic 
(GTC) seizures it could not be established 
whether the seizures were of primary or secon- 
dary generalized type. Seven patients had pri- 
mary generalized seizures with absences, myo- 
clonias, and GTC-seizures (Table 2). 
Epilepsy prevalence 
Twelve patients (17%) were diagnosed as having 
epilepsy at the time of the interview. One (8%) in 
Group 1, five (15%) in Group 2 and six patients 
(24%) in Group 3. 
Age of onset 
None of the patients had an onset in infancy or 
early childhood. Two patients had onset of 
seizures in their teens. One patient (Table 2, case 
6) with generalized seizures had onset eight years 
after a swimming pool accident with asphyxia. 
The rest with generalized seizures had onset of 
seizures between 28 and 51 years of age (Table 2). 
Seizure type 
Two patients were diagnosed as having complex 
partial seizures. One was a female (case 82) with 
cerebral palsy due to an embolus. Previous EEG 
had shown a spike focus over the left temporal 
lobe. The second patient (case 72) also had a 
spike focus in the left temporal lobe in the EEG, 
the cause of which could not be established. 
Treatment 
Ten of the twelve patients with seizures were 
treated with antiepileptic medication (Table 2). 
One patient (case 24) had previously been treated 
with phenytoin without effect and the medication 
had been discontinued. Only one patient had 
never received any antiepileptic medication ac- 
cording to his medical record (case 40). 
Concomitant diseases predisposing to epilepsy 
A previous medical history was sometimes 
difficult to obtain. Perinatal asphyxia was re- 
corded in one patient (case 6), while no 
information on perinatal problems was available 
for five patients (cases 24, 40, 72, 95). One patient 
(case 40) had a history of cerebral concussion, 
and no information of previous medical history 
was available for patient No. 72. Febrile seizures 
in childhood were not reported in any patients, 
but no information was available in three patients 
(cases 24, 40, 72). Two patients with epilepsy had 
congenital heart disease (cases 64, 82). Evidence 
of dementia defined as a progressive loss of 
previous acquired capabilities adapted from Lai 
and Williams t6 without other explanation was 
found in four patients in the oldest group (cases 
Table 2: Onset and type of seizures, EEG-findings, antiepileptic drug treatment and place of residence in the 12 patients with 
epilepsy 
Case Sex Age Age at Seizure type EEG AED Place of residence 
onset 
82 F 16 I 1 Complex partial Not done Valproate. vigabatrin Family home 
72 M 27 25 Complex partial Spikefocus Carbamazepine. phenobarbital Community unit 
06 M 23 20 Absence + tonic + atomic Normal Carbamazepinc Family home 
16 M 28 28 Absence + myoclonia Low-frequency Carbamazepine Family home 
24 M 50 35 Absence + myoclonia Low-frequency None Community unit 
23 F 60 46 Absence + myoclonia + GTC Spikefocus +low-frequency Valproate, oxacarbazepine Institution 
40 M 55 37 Absence Spikefocus +low-frequency None Community unit 
64 F 55 51 Myoclonia + GTC Not done Valproate Institution 
71 M 52 50 Myoclonia + GTC Not done Valproate Institution 
I1 M 28 15 Generalized, not-classified Not done Carbamazepine Community unit 
95 M 29 29 Generalized, not-classified Normal Carbamazepine Community unit 
92 M 58 36 Generalized, not-classified Low-frequency Phenobarbital Institution 
GTC, generalized tonic-clonic; AED, antiepileptic drugs. 
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24, 40, 64, 71). All four had generalized epilepsy 
with absences and/or myoclonia (Table 2). 
EEG 
An EEG was recorded in 50 patients, and was 
normal in 31 (62%). Among the 19 patients with 
an abnormal EEG, epileptic activity was present 
in seven patients. Three of them had clinical 
epilepsy defined as two or more epileptic seizures. 
Conclusions of the EEG for the patients with 
epilepsy are listed in Table 2. Abnormal low- 
frequency was present in 15 patients. Fourteen 
had a diffuse distribution with slowing pre- 
dominantly symmetrically over the temporal 
lobes. One patient with a previous cerebral 
embolus had a focal distribution. The EEG 
results are listed in Table 3. 
DISCUSSION 
We have showed an increased prevalence of 
epilepsy in Down syndrome with increasing age 
as only 8% in the youngest group in contrast with 
24% in the elderly group had epilepsy. To our 
knowledge this study and the studies of Collacott 9
and Prasher 7 are the only studies of the pre- 
valence of epilepsy in a complete and epidemiol- 
ogically well-described adult Down syndrome 
population. Our results are in accordance with 
the results of Collacott and Prasher. Combining 
the two younger groups (Groups 1 and 2), the 
prevalence of epilepsy is 13%. This is similar to 
the results in previous studies of younder adult 
patients with Down syndrome ~2'23"24 although 
most studies have selected either institutionalized 
patients or patients living at home. 
The distribution of seizure types in our study is 
different from that of a recent study 12 including 
children. This suggests that the distribution of 
seizure types in Down syndrome are age depen- 
Table 3: EEG abnormalities 
Group 1 2 3 Total 
EEG (n) 9 26 15 50 
Normal 8 16 7 31 (62%) 
Abnormal* 1 10 8 19 (38%) 
Epileptic activity 1 3 3 7 
Reduced dominant activity 0 2 2 4 
Non-focal ow-frequency 0 7 7 14 
Focal low-frequency 0 1 0 1 
* More than one abnormality may be present in the same 
EEG. 
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dent (as in the general population). None of our 
patients had a history of West syndrome, 
Lennon-Gastaut syndrome, other classical 
childhood epilepsy syndromes, reflex epilepsy or 
febrile seizures as described in previous 
studies '5"25. The age of onset of epilepsy in most 
of the patients is over 30 years. This might 
indicate that children with these syndromes do 
not survive until adulthood and that the lifetime 
risk of epilepsy in Down syndrome may be higher 
than previously reported. This assumption eeds 
confirmation in longitudinal studies. 
The description of seizures in patients with 
mental retardation is mainly given by parents 
and/or carers. This introduces inaccuracies in the 
classification 26and may explain why, for example, 
no simple partial seizures were registered. 
The high frequency of myoclonias in Down 
syndrome, especially in elderly patients, has been 
explained by the frequent and early onset of 
dementia in Down syndrome. Genetic mapping 
has localized a gene for progressive myoclonic 
epilepsy (Unverricht-Lundborg type) and juve- 
nile myoclonic epilepsy to chromosome 2127. The 
presence of Alzheimer's disease in Down syn- 
drome has been explained by a dose effect of the 
amyloid precursor protein gene on chromosome 
2128-3°. A similar dose effect of the gene for 
myoclonias might be another explanation for the 
frequent coexistence of Alzheimer's disease and 
myoclonias in Down syndrome. 
In healthy, elderly people the EEG shows an 
increased prevalance of abnormal low-frequency 
of about 35% 31. The few studies on EEG in 
elderly patients with Down syndrome 32"33 all 
report an even higher prevalence of abnormal 
low-frequency, in part related to dementia 16'34"35. 
This is in keeping with the 47% of abnormal 
low-frequency seen in this study. 
In conclusion, the present study suggests that 
patients with Down syndrome and epilepsy often 
have primary generalized seizures starting in 
adulthood with absences and/or myoclonias 
and/or GTC seizures. This constellation of 
epilepsy may be a special type of progressive 
myoclonic epilepsy associated with the gene for 
myoclonias located on chromosome 21. This 
should be elucidated in longitudinal clinical and 
genetic 
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